179 related articles for article (PubMed ID: 16617690)
21. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
Rabijewski M; Zgliczyński W
Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
[TBL] [Abstract][Full Text] [Related]
22. Influence of oral dehydroepiandrosterone (DHEA) on urinary steroid metabolites in males and females.
Callies F; Arlt W; Siekmann L; Hübler D; Bidlingmaier F; Allolio B
Steroids; 2000 Feb; 65(2):98-102. PubMed ID: 10639021
[TBL] [Abstract][Full Text] [Related]
23. [Replacement and supplementation of DHEA--is it a wellness hormone?].
Brückel J
MMW Fortschr Med; 2005 Feb; 147(7):30-2. PubMed ID: 18441581
[TBL] [Abstract][Full Text] [Related]
24. [A case report of mania precipitated by use of DHEA].
Vacheron-Trystram MN; Cheref S; Gauillard J; Plas J
Encephale; 2002; 28(6 Pt 1):563-6. PubMed ID: 12506269
[TBL] [Abstract][Full Text] [Related]
25. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.
Pillemer SR; Brennan MT; Sankar V; Leakan RA; Smith JA; Grisius M; Ligier S; Radfar L; Kok MR; Kingman A; Fox PC
Arthritis Rheum; 2004 Aug; 51(4):601-4. PubMed ID: 15334433
[TBL] [Abstract][Full Text] [Related]
26. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
27. Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation.
van Niekerk JK; Huppert FA; Herbert J
Psychoneuroendocrinology; 2001 Aug; 26(6):591-612. PubMed ID: 11403980
[TBL] [Abstract][Full Text] [Related]
28. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men.
Kahn AJ; Halloran B; Wolkowitz O; Brizendine L
J Clin Endocrinol Metab; 2002 Apr; 87(4):1544-9. PubMed ID: 11932279
[TBL] [Abstract][Full Text] [Related]
29. Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations.
Lubet RA; Gordon GB; Prough RA; Lei XD; You M; Wang Y; Grubbs CJ; Steele VE; Kelloff GJ; Thomas CF; Moon RD
Cancer Res; 1998 Mar; 58(5):921-6. PubMed ID: 9500451
[TBL] [Abstract][Full Text] [Related]
30. [DHEA: orthodox or alternative medicine?].
Cogan E
Rev Med Brux; 2001 Sep; 22(4):A381-6. PubMed ID: 11680205
[TBL] [Abstract][Full Text] [Related]
31. Long-term administration of intravaginal dehydroepiandrosterone on regression of low-grade cervical dysplasia--a pilot study.
Suh-Burgmann E; Sivret J; Duska LR; Del Carmen M; Seiden MV
Gynecol Obstet Invest; 2003; 55(1):25-31. PubMed ID: 12624548
[TBL] [Abstract][Full Text] [Related]
32. Clinical Significance of Human Papillomavirus Type 16 for Breast Cancer & Adenocarcinomas of Various Internal Organs and Alzheimer's Brain with Increased β-amyloid (1-42); Combined Use of Optimal Doses of Vitamin D3 and Taurine 3 times/day Has Significant Beneficial Effects of Anti-Cancer, Anti-Ischemic Heart, and Memory & Other Brain Problems By Significant Urinary Excretion of Viruses, Bacteria, and Toxic Metals & Substances.
Omura Y
Acupunct Electrother Res; 2016; 41(2):127-134. PubMed ID: 29897688
[TBL] [Abstract][Full Text] [Related]
33. Dehydroepiandrosterone (DHEA) and the menopause: an update.
Raven PW; Hinson JP
Menopause Int; 2007 Jun; 13(2):75-8. PubMed ID: 17540138
[TBL] [Abstract][Full Text] [Related]
34. [Is there an indication for dehydroepiandrosterone (DHEA) treatment in elderly women with Addison disease? Beneficial and adverse effects of DHEA].
Martin-Du Pan RC
Rev Med Suisse Romande; 2001 Sep; 121(9):649-54. PubMed ID: 11723706
[TBL] [Abstract][Full Text] [Related]
35. Dehydroepiandrosterone supplementation combined with Weight-Loading Whole-Body Vibration Training (WWBV) affects exercise performance and muscle glycogen storage in middle-aged C57BL/6 mice.
Chen YM; Lee HC; Chen MT; Huang CC; Chen WC
Int J Med Sci; 2018; 15(6):564-573. PubMed ID: 29725246
[No Abstract] [Full Text] [Related]
36. Oral dehydroepiandrosterone inhibits the growth of human pancreatic cancer in nude mice.
Muscarella P; Boros LG; Fisher WE; Rink C; Melvin WS
J Surg Res; 1998 Oct; 79(2):154-7. PubMed ID: 9758731
[TBL] [Abstract][Full Text] [Related]
37. Dehydroepiandrosterone effects on Akt signaling modulation in central nervous system of young and aged healthy rats.
Janner Dda R; Jacob MH; Jahn MP; Kucharski LC; Ribeiro MF
J Steroid Biochem Mol Biol; 2010 Oct; 122(4):142-8. PubMed ID: 20691781
[TBL] [Abstract][Full Text] [Related]
38. Effects of topical DHEA on aging skin: a pilot study.
Nouveau S; Bastien P; Baldo F; de Lacharriere O
Maturitas; 2008 Feb; 59(2):174-81. PubMed ID: 18242894
[TBL] [Abstract][Full Text] [Related]
39. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS.
Rabkin JG; McElhiney MC; Rabkin R; McGrath PJ; Ferrando SJ
Am J Psychiatry; 2006 Jan; 163(1):59-66. PubMed ID: 16390890
[TBL] [Abstract][Full Text] [Related]
40. DHEA, important source of sex steroids in men and even more in women.
Labrie F
Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
